Statin Therapy in Patients With Early Stage ADPKD

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

August 31, 2017

Primary Completion Date

March 25, 2024

Study Completion Date

September 30, 2025

Conditions
ADPKDAutosomal Dominant Polycystic Kidney
Interventions
DRUG

Pravastatin

Anti-inflammatory, anti-oxidative stress, and anti-proliferative therapy

DRUG

Placebo

Inactive tablet

Trial Locations (1)

80045

University of Colorado Denver Anschutz Medical Campus, Denver

All Listed Sponsors
lead

University of Colorado, Denver

OTHER